Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Baird analyst Joel Beatty initiated coverage on Catalyst Pharmaceuticals, Inc CPRX with an Outperform rating and announced a price target of $28. Catalyst Pharmaceuticals shares closed at $22.62 on Monday. See how other analysts view this stock.
- Raymond James analyst John Freeman initiated coverage on Expand Energy Corporation EXE with a Strong Buy rating and announced a price target of $135. Expand Energy shares closed at $102.87 on Monday. See how other analysts view this stock.
- BMO Capital analyst John Kim initiated coverage on Terreno Realty Corporation TRNO with a Market Perform rating and announced a price target of $71. Terreno Realty shares closed at $65.26 on Monday. See how other analysts view this stock.
- Wolfe Research analyst Andy Chen initiated coverage on Vera Therapeutics, Inc. VERA with an Outperform rating and announced a price target of $49. Vera Therapeutics shares closed at $36.54 on Monday. See how other analysts view this stock.
- Wolfe Research analyst Andy Chen initiated coverage on Oruka Therapeutics, Inc. ORKA with an Outperform rating and announced a price target of $20. Oruka Therapeutics shares closed at $13.70 on Monday. See how other analysts view this stock.
Considering buying EXE stock? Here’s what analysts think:
Overview Rating:
Speculative
Market News and Data brought to you by Benzinga APIs
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
